/Lilly(Eli)%20%26%20Co%20logo%20on%20building-by%20Michael%20Vi%20via%20Shutterstock.jpg)
Eli Lilly and Company (LLY), with a market cap of $733.85 billion, is a global leader in the pharmaceutical industry. Headquartered in Indianapolis, Indiana, Eli Lilly is dedicated to discovering, developing, and delivering innovative medicines that improve quality of life. With a robust portfolio of treatments spanning various therapeutic areas, Eli Lilly serves millions of patients globally, focusing on critical health challenges such as diabetes, cancer, and mental health.
Eli Lilly has significantly outperformed the broader market over the last year. The stock has gained 62.1% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 18.2%. Also, in 2024, the stock is up 45% compared to SPX's 11.5% gains on a YTD basis.
